Evidence Based Healthcare : Overcoming Barriers in Europe


Regular Price: USD 12,440.00

Special Price USD 8,708.00

30% OFF

* Required Fields

Regular Price: USD 12,440.00

Special Price USD 8,708.00


Be the first to review this product

This report examines the many strands which are influencing this situation, and identifies a range of companies that are putting together coherent market strategies - and some that are not.

Table of Contents

Evidence Based Healthcare , Executive SummaryExecutive SummaryExecutive SummaryEvidence Based Healthcare , Introduction Aims and ObjectivesIntroductionIntroductionAims and ObjectivesAims and ObjectivesEvidence Based Healthcare , Managing Healthcare QualityManaging Healthcare QualityManaging Healthcare QualityThe Advent of ControlThe Advent of ControlThe Results of ChangeThe Results of ChangeThe Quality ParadigmIntroductionProduct UsageHealth Technology AssessmentTreatmentsDisease ManagementEvidenced-Based MedicineTreatment Definition: Guidelines; Protocols and PathwaysDepartmental Activity: Work FlowThe Global Environment; Needs Assessment and PlanningTotal Quality ControlSolutions; Treatments and Packages of CareTreatment "Manufacture"The Management of InnovationThe Marketing of Healthcare ProductsThe Marketing of Healthcare ProductsThe Role of Information TechnologyThe Role of Information TechnologySummarySummaryEvidence Based Healthcare , European InitiativesThe Aims of the ChapterThe Aims of the ChapterThe Impact of the EUThe Impact of the EUHealthcare Technology AssessmentIntroductionThe Impact of HTA on HealthcareReimbursementIntroductionProcedure-level reimbursementReimbursement FormulariesProvider AmalgamationProvider AmalgamationThe Role of PlanningIntroductionDisease ManagementInformation Technology Initiatives Information Technology Initiatives Evidence Based Healthcare , The Barriers and Opportunities for a Range of Industry SectorsIntroductionIntroductionPharmaceutical CompaniesIntroductionSpending Too Much on Out-dated Approaches to MarketingTailored Treatment SolutionsConclusionsMedical Product CompaniesIntroductionGeneral Electric Medical SystemsSiemens Medical EngineeringPhilips Medical SystemsConclusionsPharmaceutical WholesalersPharmaceutical WholesalersPharmaciesPharmaciesHealthcare IT CompaniesThe Application of IT in HealthcareTrends in Disease Management in the USAConclusionsHealthcare ProvidersHealthcare ProvidersConsultancy CompaniesConsultancy CompaniesEvidence Based Healthcare , Opportunities and Strategies for European CompaniesOpportunities and Strategies for European CompaniesOpportunities and Strategies for European CompaniesGeneral Strategic ImperativesGeneral Strategic ImperativesSummary of Opportunities for a Range of Company TypesDistribution Channels for Home-Based PatientsCase StudiesIntroductionThe Pharmaceutical SectorAventis Pharma – Sponsoring a Diabetes PilotEli Lilly – Piloting Disease Management of DiabetesMerck & Co. Inc.Pfizer – Bonding Information Technology and Pharmaceuticals and Innovating the Initiation of Disease ManagementRoche – Integrating Therapeutics and DiagnosticsSchering-Plough – Integrated Therapeutics with a Significant IT ComponentMedical Product and Service CompaniesBaxter International – Significant Renal Resource but no Disease Management in EuropeClinovia Limited – Under-exploited High-Technology HomecareFresenius – Moving from Products into Care ProvisionGEHE – Concentrating on ExpansionMcKesson Corporation – IT Support for Disease ManagementPhilips Medical – Integrating Technologies the Electromedical WaySHL TeleMedicine – Telemedicine to Disease Management ServiceUS-based Disease Management Service CompaniesWinners and LosersWinners and LosersEvidence Based Healthcare , Frost & Sullivan AwardsMarket LeadershipAward DescriptionResearch MethodologyAward Winner- Hoffman – La Roche

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.